Skip to content

Predictors of Treatment Expectations in Myofascial Pain Syndrome

Determining the Predictors of Treatment Expectations in Individuals With Myofascial Pain Syndrome: A Cross-Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07689396
Enrollment
97
Registered
2026-07-08
Start date
2026-07-01
Completion date
2026-08-28
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndromes

Keywords

pain, myofascial pain syndrome, treatment expectation, quality of life, fatigue

Brief summary

This cross-sectional study aims to determine the predictors of treatment expectations in individuals with myofascial pain syndrome (MPS). MPS is one of the most common causes of musculoskeletal pain and is associated with reduced quality of life. Patients' pre-treatment expectations are known to influence clinical outcomes, yet the factors that predict these expectations have not been established. Adults diagnosed with MPS who are scheduled to receive physiotherapy complete measures of treatment expectations, pain intensity and duration, health-related quality of life, and fatigue. Multiple regression analysis is used to examine the extent to which pain intensity, pain duration, quality of life, and fatigue predict treatment expectations.

Detailed description

Design and setting: Cross-sectional, descriptive study conducted at a private physiotherapy clinic in Konya, Turkiye, between April and August 2026. Participants: Adults (18 years and older) with a diagnosis of MPS, a pain intensity of at least 3 on a visual analog scale, and scheduled to receive at least two weeks of physiotherapy. Individuals with a psychiatric diagnosis, a chronic systemic disease, or any barrier preventing communication are excluded. Sample size: Based on an a priori power analysis (G\*Power; effect size 0.15, power 0.80, alpha 0.05), a minimum of 85 participants is required. Measures: A personal information form; the Treatment Expectation Questionnaire (TEX-Q), Turkish version, as the dependent variable; pain intensity and duration via a visual analog scale; health-related quality of life via the Short Form-36 (SF-36); and fatigue via the Brief Fatigue Inventory (BFI). Analysis: Descriptive statistics, the Shapiro-Wilk test for normality, and multiple linear regression models (with 95% confidence intervals) to examine the associations between treatment expectations and pain intensity, pain duration, quality of life, and fatigue. Statistical significance is set at p\<0.05.

Interventions

None listed

Sponsors

KTO Karatay University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Diagnosis of myofascial pain syndrome * Pain intensity of at least 3 on the Visual Analog Scale * Scheduled to receive at least two weeks of physiotherapy

Exclusion criteria

* Diagnosed psychiatric disorder * Chronic systemic disease * Any barrier preventing communication

Design outcomes

Primary

MeasureTime frameDescription
Treatment expectationsAt enrollment, before the physiotherapy program (single cross-sectional assessment)Measured with the Treatment Expectation Questionnaire (TEX-Q), Turkish version. The total score of the first 15 items ranges from 0 to 150, with higher scores indicating greater treatment expectations.

Secondary

MeasureTime frameDescription
Pain intensityAt enrollment (single cross-sectional assessment)Assessed with a 10 cm Visual Analog Scale (VAS) for rest, activity, and night pain; 0 = no pain, 10 = unbearable pain.
Pain durationAt enrollment (single cross-sectional assessment)Self-reported duration of pain complaints, recorded in weeks.
Health-related quality of lifeAt enrollment (single cross-sectional assessment)Assessed with the Short Form-36 (SF-36). Subscale scores range from 0 to 100, with higher scores indicating better health status.
FatigueAt enrollment (single cross-sectional assessment)Assessed with the Brief Fatigue Inventory (BFI); higher scores indicate greater fatigue.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORHasan Gercek, PT, PhD

KTO Karatay University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026